Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Advantage of Switching From Preserved to Preserved-free Treatments in Glaucoma. A Clinical and Confocal Study.

NCT01433900 is registered in ClinicalTrials.gov with Paolo Fogagnolo as lead sponsor.

NCT NCT01433900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01433900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Advantage of Switching From Preserved to Preserved-free Treatments in Glaucoma. A Clinical and Confocal Study.
Lead sponsor
Paolo Fogagnolo
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2012
Completion date
June 30, 2014
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma